F03 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Business PotentialRAL is preferred for realizing a steeper 1H'25 trough and brings clearer potential.
Tariff RatesLower tariff rates likely help a few cents in the second half.
ValuationShares are inexpensive and NT Street estimates look achievable.
Bears Say
Business StructureIt's still a fairly odd combo of businesses that is now de-emphasizing mergers and acquisitions compared to prior.
Growth ChallengesA significant improvement in multiples will be difficult to achieve until faster, organic growth emerges.
Organic Growth UncertaintyFTV organic growth has slowed to flattish with approximately 40% of company revenue tied to Government and Healthcare spend, the recovery pathway is unclear and clouded by US policy uncertainty.
Fortive News
F03 FAQ
What was Fortive Corp’s price range in the past 12 months?
Currently, no data Available
What is Fortive Corp’s market cap?
Fortive Corp’s market cap is CHF15.14B.
When is Fortive Corp’s upcoming earnings report date?
Fortive Corp’s upcoming earnings report date is Oct 28, 2026 which is in 73 days.
How were Fortive Corp’s earnings last quarter?
Fortive Corp released its earnings results on Jul 29, 2026. The company reported CHF0.602 earnings per share for the quarter, beating the consensus estimate of CHF0.576 by CHF0.027.
Is Fortive Corp overvalued?
According to Wall Street analysts Fortive Corp’s price is currently Undervalued.
Does Fortive Corp pay dividends?
Fortive Corp does not currently pay dividends.
What is Fortive Corp’s EPS estimate?
Fortive Corp’s EPS estimate is 0.57.
How many shares outstanding does Fortive Corp have?
Currently, no data Available
What happened to Fortive Corp’s price movement after its last earnings report?
Fortive Corp reported an EPS of CHF0.602 in its last earnings report, beating expectations of CHF0.576. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Fortive Corp?
Currently, no hedge funds are holding shares in CH:F03
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fortive Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
CHF52.24 (― Upside)
CHF52.24 (― Upside)
Blogger Sentiment
Bullish
CH:F03 Sentiment 75%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth CHF432.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-36.34%
Trailing 12-Months
Company Description
Fortive Corp
Fortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection. These products and services cater to diverse industries such as manufacturing, process industries, healthcare, utilities and power generation, communications, and electronics. Key brands within this segment include ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL. The company's Precision Technologies segment focuses on delivering critical measurement and control solutions. Its portfolio encompasses electrical testing and measurement instruments and related services, high-performance energetic material devices, and advanced sensor and control system solutions. These technologies are crucial for demanding sectors like power and energy management, medical equipment manufacturing, food and beverage production, aerospace and defense, off-highway vehicles, electronics, semiconductor fabrication, and various other industrial applications. This segment markets its offerings under brands such as ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX. Fortive's Advanced Healthcare Solutions division provides a comprehensive suite of hardware, software, and services specifically designed for the healthcare sector. This includes solutions for reprocessing and tracking medical instruments and devices, specialized biomedical testing tools, systems for radiation safety monitoring, and asset management services. Additionally, it offers subscription-based surgical inventory management platforms that optimize inventory and ensure regulatory adherence, alongside expert technical, analytical, and compliance services focused on determining radiation exposure. Brands in this segment include ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD. Established in 2015, Fortive Corporation maintains its corporate headquarters in Everett, Washington.
F03 Company Deck
F03 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: double‑digit adjusted EPS growth (+28% YoY), solid core revenue growth (6.7% in Q2), raised full‑year EPS guidance, strong free cash flow (Q2 ~$270M; trailing 12‑month >$1B), aggressive buybacks (~$200M in Q2; ~$2B since spin‑off), and tangible product and AI innovations driving commercial traction. Near‑term headwinds and watch‑items include gross margin compression driven by mix (~100–110 bps), modest EMEA weakness, Q3 seasonality and a Q4 selling‑day headwind (~$15–$20M and ~150 bps to core growth), tariff refund treatment, and ongoing supply/inflation risks. Overall, the positives — revenue/earnings acceleration, cash generation, shareholder returns, and visible product momentum — outweigh the transitory and manageable lowlights.View all CH:F03 earnings summariesF03 Sales Breakdown
68.68% Intelligent Operating Solutions
31.32% Advanced Healthcare Solutions
0.00% Unallocated Corporate Costs and Other

F03 Stock 12 Month Forecast
All Analysts
Top Analysts








